Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository. Efficacy and ...
They then used Poisson regression to compare overall and sex-specific yearly AH rates and assessed correlations between female sex and incident cirrhosis and/or decompensation as well as sex ...
FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim. According to data from Cancer Research UK, up to 70 per cent of all these ...
A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...
These might seem like minor inconveniences, but for people with primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis they can be the first signs of liver disease. PBC is a ...